Infection-Related Cancers in Sub-Saharan Africa: A Paradigm for Cancer Prevention and Control

被引:10
作者
Okuku, Fred [1 ]
Omoding, Abrahams [1 ]
Walusansa, Victoria [1 ]
Origa, Martin [1 ]
Mutungi, Gerald [2 ]
Orem, Jackson [1 ]
机构
[1] Uganda Canc Inst, Kampala, Uganda
[2] Minist Hlth, Kampala, Uganda
关键词
Infection; Cancer; Sub-Saharan Africa; Communicable diseases; Noncommunicable diseases; KAPOSIS-SARCOMA; CERVICAL-CANCER; BURKITTS-LYMPHOMA; RISK-FACTORS; HEPATITIS-B; HIV; IMMUNODEFICIENCY; VACCINE; TARGETS; BURDEN;
D O I
10.1159/000343151
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is much commonality between chronic noncommunicable and communicable diseases which is best exemplified by cancers of infectious origin. It provides the perfect opportunity for harnessing the advances that have been made in the control of communicable diseases to attempt the control of noncommunicable diseases. There are possibilities at various levels of intervention, at primary, secondary and tertiary levels, which fit well within a well-planned national cancer control strategy. Prevention should proceed through steps of disruption of transmission, improvement in disease recognition and diagnosis, as well as through prompt effective treatment. This principle should work for both infection and the resultant cancer. Research is very important in understanding how best to use the available knowledge and how best to sequentially implement strategies. Finally, policies that acknowledge infection-related cancers as a major problem in the region should be in place. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:75 / 80
页数:6
相关论文
共 42 条
  • [1] [Anonymous], 1999, J Pharm Belg, V54, P59
  • [2] Potential Impact of Antiretroviral Therapy and Screening on Cervical Cancer Mortality in HIV-Positive Women in Sub-Saharan Africa: A Simulation
    Atashili, Julius
    Smith, Jennifer S.
    Adimora, Adaora A.
    Eron, Joseph
    Miller, William C.
    Myers, Evan
    [J]. PLOS ONE, 2011, 6 (04):
  • [3] Basu M, 2006, Indian J Cancer, V43, P139
  • [4] Hepatitis B virus, the vaccine, and the control of primary cancer of the liver
    Blumberg, BS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7121 - 7125
  • [5] Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study
    Bohlius, Julia
    Schmidlin, Kurt
    Costagliola, Dominique
    Faetkenheuer, Gerd
    May, Margaret
    Maria Caro-Murillo, Ana
    Mocroft, Amanda
    Bonnet, Fabrice
    Clifford, Gary
    Karafoulidou, Anastasia
    Miro, Jose M.
    Lundgren, Jens
    Chene, Genevieve
    Egger, Matthias
    [J]. ANTIVIRAL THERAPY, 2009, 14 (08) : 1065 - 1074
  • [6] Developing an HPV vaccine to prevent cervical cancer and genital warts
    Bryan, Janine T.
    [J]. VACCINE, 2007, 25 (16) : 3001 - 3006
  • [7] Chokunonga E, 2011, IARC Sci Publ, P249
  • [8] Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: Bidirectional translational science
    Dezube, Bruce J.
    Sullivan, Ryan
    Koon, Henry B.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 209 (03) : 659 - 662
  • [9] Issues in cervical cancer incidence and treatment in HIV
    Einstein, Mark H.
    Phaeton, Rebecca
    [J]. CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) : 449 - 455
  • [10] Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression
    Feng, Wen-hai
    Kenney, Shannon C.
    [J]. CANCER RESEARCH, 2006, 66 (17) : 8762 - 8769